These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7688828)
1. Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. Jones EA; Bolyard AA; Dale DC JAMA; 1993 Sep; 270(9):1132-3. PubMed ID: 7688828 [TBL] [Abstract][Full Text] [Related]
2. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Fazio MT; Glaspy JA Oncol Nurs Forum; 1991; 18(8):1411-4. PubMed ID: 1722310 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia. Cohen AM; Hodak E; David M; Mittelman M; Gal R; Stern R Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony stimulating factor in the management of chronic neutropenia. Marlton PV; Wright SJ; Taylor KM Med J Aust; 1992 May; 156(10):729-31. PubMed ID: 1377771 [TBL] [Abstract][Full Text] [Related]
5. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210 [TBL] [Abstract][Full Text] [Related]
6. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study. Salehi T; Fazlollahi MR; Maddah M; Nayebpour M; Tabatabaei Yazdi M; Alizadeh Z; Eshghi P; Chavoshzadeh Z; Movahedi M; Hamidieh AA; Cheraghi T; Pourpak Z; Moin M Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476 [TBL] [Abstract][Full Text] [Related]
14. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173 [TBL] [Abstract][Full Text] [Related]
15. [Recombinant granulocyte colony-stimulating factor as a new effective treatment of neutropenia]. Fasth A; Carlson G; Ridell B Lakartidningen; 1992 Mar; 89(10):776-80. PubMed ID: 1371816 [No Abstract] [Full Text] [Related]
16. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor. Cooper DL; Henderson-Bakas M; Berliner N Cancer; 1993 Sep; 72(5):1607-11. PubMed ID: 7688654 [TBL] [Abstract][Full Text] [Related]
17. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia. Bernini JC; Wooley R; Buchanan GR J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262 [TBL] [Abstract][Full Text] [Related]
18. Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia. Kearns CM; Wang WC; Stute N; Ihle JN; Evans WE J Pediatr; 1993 Sep; 123(3):471-9. PubMed ID: 7689097 [TBL] [Abstract][Full Text] [Related]
19. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital. Osmani AH; Ansari TZ; Masood N; Ahmed B Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399 [TBL] [Abstract][Full Text] [Related]
20. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia. Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]